[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

Re: [IP] Pump Therapy study pregnancy and Type 1

Whoever posted this: THANKS!!!  My husband and I just went through artificial
insemination this weekend and I would love any and all info, experiences, and
advice about pumping while pregnant.  Thanks again.

email @ redacted wrote:

> Am J Obstet Gynecol 2000 Jun;182(6):1283-1291 Related Articles, Books,
> LinkOut
> Benefits, risks, costs, and patient satisfaction associated with insulin pump
> therapy for the pregnancy complicated by type 1 diabetes mellitus.
> Gabbe SG, Holing E, Temple P, Brown ZA
> Diabetes in Pregnancy Program, Departments of Obstetrics and Gynecology and
> Pediatrics, University of Washington Medical Center.
> [Record supplied by publisher]
> OBJECTIVE: Glycemic control, perinatal outcome, and health care costs were
> evaluated among women with type 1 diabetes mellitus who began insulin pump
> therapy during pregnancy (group 1, n = 24), were treated with multiple
> insulin injections (group 2, n = 24), or were already using an insulin pump
> before pregnancy (group 3, n = 12). Patient satisfaction and continuation of
> pump therapy post partum were assessed.Study Design: A retrospective review
> of maternal and neonatal medical records was performed, and a questionnaire
> was sent to patients after delivery. Patients in groups 1 and 2 were matched
> for age, age at onset and duration of diabetes mellitus, White class, and
> date of delivery. RESULTS: No differences in glycosylated hemoglobin A levels
> were observed among groups 1, 2 or 3 in the first, second, or third
> trimester. Patients in group 1 started pump therapy at a mean of 16.8 weeks'
> gestation, and 17 (70.8%) began therapy as outpatients. No deterioration in
> glycemic control was noted during the 2- to 4-week period after the start of
> pump treatment. Among the women in group 1 eight had at least one episode of
> severe hypoglycemia before starting pump therapy, but only one had such an
> episode after this treatment was begun. Two episodes of ketoacidosis occurred
> in group 1, and no episodes occurred in groups 2 and 3. No significant
> differences in perinatal outcomes or health care costs were observed among
> groups 1, 2, and 3. After delivery 94.7% of the women in group 1 continued to
> use the pump because it provided better glycemic control and a more flexible
> lifestyle. Postpartum glycosylated hemoglobin A values were 7.2% in group 1
> and 9.1% in group 2, a significant difference. CONCLUSIONS: Insulin pump
> therapy was initiated during pregnancy without a deterioration of glycemic
> control and was associated with maternal and perinatal outcomes and health
> care costs comparable to those among women who were already using the pump
> before pregnancy or who received multiple-dose insulin therapy. Women who
> began pump therapy in pregnancy were highly likely to continue pump use after
> delivery and preferred the flexible lifestyle that this treatment allowed.
> PMID: 10871440  <A
> HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&lis
> t_uids=10871440&dopt=Abstract">Entrez-PubMed</A>
> ----------------------------------------------------------
> for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
> send a DONATION http://www.Insulin-Pumpers.org/donate.shtml

for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml